חזרה לתוצאות החיפוש

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Multiple Myeloma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Susan Bal) · 205-934-1908

  • Mayo Clinic in Arizona - Phoenix, Phoenix, Arizona, United States

    Contact: Study coordinator (Julia Wiedmeier-Nutor) · 855-776-0015

  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Myo Htut) · 626-256-4673

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Sikander Ailawadhi) · 904-953-0853

  • Northside Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Scott Solomon) · 404-255-1930

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Jacalyn Rosenblatt) · 617-667-9920

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Omar Nadeem) · 617-632-3000

  • Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota, United States

    Contact: Study coordinator (Taxiarchis Kourelis) · 855-776-0015

  • University Of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Christopher D'Angelo) · 402-559-8110

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (David Siegel) · 551-996-8704

  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Ehsan Malek) · 216-286-4441

  • Laura and Isaac Perlmutter Cancer Center, New York, New York, United States

    Contact: Study coordinator (Jingmei Hsu) · 646-501-4848

  • Local Institution - 0009, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Sham Mailankody) · 646-608-3712

  • Local Institution - 0023, Pittsburgh, Pennsylvania, United States

  • Tennessee Oncology, Nashville, Tennessee, United States

    Contact: Study coordinator (Jesus Berdeja) · 615-329-0570

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Krina Patel) · 713-792-6662

  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Nizar Bahlis) · 4032202801

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Christine Chen) · 4169464501
מובילי המחקר

  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)